本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ANI Pharmaceuticals, Inc.

74.95
+1.361.84%
成交量:24.95萬
成交額:1,864.15萬
市值:17.22億
市盈率:16.51
高:75.20
開:73.68
低:73.54
收:73.59
52周最高:98.55
52周最低:69.58
股本:2,297.04萬
流通股本:2,028.20萬
量比:0.82
換手率:1.23%
股息:- -
股息率:- -
每股收益(TTM):4.54
每股收益(LYR):3.32
淨資產收益率:20.46%
總資產收益率:5.45%
市淨率:2.88
市盈率(LYR):22.57

資料載入中...

2024/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/29

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/23

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/08

重要事件披露

Form 8-K - Current report
2024/01/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/17

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/18

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities